↓ Skip to main content

Deciding when to stop: towards evidence-based deprescribing of drugs in older populations

Overview of attention for article published in BMJ Evidence-Based Medicine, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

policy
1 policy source
twitter
38 X users
facebook
5 Facebook pages

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
221 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Deciding when to stop: towards evidence-based deprescribing of drugs in older populations
Published in
BMJ Evidence-Based Medicine, November 2012
DOI 10.1136/eb-2012-100930
Pubmed ID
Authors

Ian A Scott, Leonard C Gray, Jennifer H Martin, Peter I Pillans, Charles A Mitchell

Abstract

Minimising the harm from inappropriate prescribing in older populations is a major urgent concern for modern healthcare systems. In everyday encounters between prescribers and patients, opportunities should be taken to identify patients at high risk of harm from polypharmacy and reappraise their need for specific drugs. Attempts to reconcile life expectancy, comorbidity burden, care goals and patient preferences with the benefits and harms of medications should be made in every patient at significant risk. Drugs identified by this process of reconciliation as conferring little or no benefit and/or excessive risk of harm should be candidates for discontinuation. Evidence supporting a structured approach to drug discontinuation (or deprescribing) is emerging, and while many barriers to deprescribing exist in routine practice, various enabling strategies can help overcome them.

X Demographics

X Demographics

The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 221 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 2 <1%
Portugal 1 <1%
Netherlands 1 <1%
Canada 1 <1%
United States 1 <1%
Unknown 215 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 41 19%
Researcher 26 12%
Student > Ph. D. Student 26 12%
Student > Bachelor 26 12%
Student > Doctoral Student 16 7%
Other 47 21%
Unknown 39 18%
Readers by discipline Count As %
Medicine and Dentistry 88 40%
Pharmacology, Toxicology and Pharmaceutical Science 32 14%
Nursing and Health Professions 16 7%
Agricultural and Biological Sciences 7 3%
Social Sciences 7 3%
Other 29 13%
Unknown 42 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2015.
All research outputs
#1,465,430
of 25,732,188 outputs
Outputs from BMJ Evidence-Based Medicine
#185
of 1,447 outputs
Outputs of similar age
#9,165
of 199,354 outputs
Outputs of similar age from BMJ Evidence-Based Medicine
#3
of 29 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,447 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,354 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.